Identification of locomotive and metabolic syndrome-related genes by genome wide association and functional analysis
Project/Area Number |
25293214
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Endocrinology
|
Research Institution | The University of Tokyo |
Principal Investigator |
Urano Tomohiko 東京大学, 医学部附属病院, 講師 (20334386)
|
Co-Investigator(Kenkyū-buntansha) |
INOUE Satoshi 東京大学, 医学部附属病院, 特任教授 (40251251)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥18,330,000 (Direct Cost: ¥14,100,000、Indirect Cost: ¥4,230,000)
Fiscal Year 2015: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2014: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2013: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
|
Keywords | 骨粗鬆症 / サルコペニア / 肥満 / ゲノムワイド解析 / ロコモーティブ症候群 / メタボリック症候群 / 性ホルモン / Wntシグナル |
Outline of Final Research Achievements |
Osteoporosis is a skeletal disease characterized by an increased susceptibility to fractures. Evidence from genetic analyses indicates that pathogenesis of osteoporosis is genetically controlled. We show that the SLC25A32, the mitochondrial inner membrane folate transporter, gene polymorphism could be a risk factor for lower folate concentration and future fracture. Moreover, we have identified single-nucleotide polymorphisms (SNPs) that are associated with the development of sarcopenia, which is characterized by a loss of lean body mass, and obesity, which is characterized by high fat mass by genome-wide association studies (GWAS). Here, we have shown that GWAS revealed a functional SNP in the 5'-flanking region of PRDM16 gene associated with lean body mass. We also found that genetic analyses in human and knock out mouse models revealed the importance of SLC25A24/Slc25a24 in the regulation of body fat mass and adipogenesis.
|
Report
(4 results)
Research Products
(43 results)
-
-
-
-
-
-
-
[Journal Article] Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial.2015
Author(s)
Fujimura T, Takahashi S, Kume H, Urano T, Takayama K, Yamada Y, Suzuki M, Fukuhara H, Nakagawa T, Inoue S, Homma Y.
-
Journal Title
BMC Cancer.
Volume: 15
Issue: 1
Pages: 836-836
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer2015
Author(s)
Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Urano T, Takahashi S, Homma Y, Aburatani H, Inoue S
-
Journal Title
Oncotarget
Volume: 6
Pages: 2263-2276
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth2014
Author(s)
Obinata D, Ito Akiko, Fujiwara K, Takayama K, Ashikari D, Murata Y, Yamaguchi K, Urano T, Fujimura T, Fukuda N, Soma M, Watanabe T, Nagase H, Inoue S, Takahashi S
-
Journal Title
Cancer Sci
Volume: 105
Issue: 10
Pages: 1272-1278
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer2014
Author(s)
Fujimura T, Takahashi S, Urano T, Takayama K, Sugihara T, Obinata D, Yamada Y, Kumagai J, Kume H, Ouchi Y, Inoue S, Homma Y
-
Journal Title
Clin Cancer Res
Volume: 20
Issue: 17
Pages: 4625-4635
DOI
Related Report
Peer Reviewed
-
[Journal Article] Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping2014
Author(s)
Yamaga R, Ikeda K, Boele J, Horie-Inoue K, Takayama K, Urano T, Kaida K, Carninci P, Kawai J, Hayashizaki Y, Ouchi Y, de Hoon M, Inoue S
-
Journal Title
Biochem Biophys Res Commun
Volume: 447
Issue: 3
Pages: 531-536
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Liver-specific γ-glutamyl carboxylase-1 deficient mice display bleeding diathesis and short life span.2014
Author(s)
Azuma K, Tsukui T, Ikeda K, Shiba S, Nakagawa K, Okano T, Urano T, Horie-Inoue K, Ouchi Y, Ikawa M, Inoue S
-
Journal Title
PLoS ONE
Volume: 9
Issue: 2
Pages: e88643-e88643
DOI
Related Report
Peer Reviewed
-
[Journal Article] Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.2013
Author(s)
Takayama K, Horie-Inoue K, Katayama S, Suzuki T, Tsutsumi S, Ikeda K, Urano T, Fujimura T, Takagi K, Takahashi S, Homma Y, Ouchi Y, Aburatani H, Hayashizaki Y, Inoue S
-
Journal Title
EMBO J
Volume: 32
Issue: 12
Pages: 1665-1680
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
[Presentation] Expression of androgen and estrogen signaling components and stem cell markers predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.2014
Author(s)
Fujimura T, Takahashi S, Urano T, Kume H, Takayama K, Murata T, Yamada Y, Obinata D, Inoue S, Homma Y
Organizer
109th American Urological Association Annual Meeting
Place of Presentation
Orlando, FL, USA
Year and Date
2014-05-16 – 2014-05-21
Related Report
-
-
-
[Presentation] Expression of androgen and estrogen signaling components and stem cell markers is highly predictive of cancer progression of metastatic prostate cancer.2014
Author(s)
Fujimura T, Takahashi S, Urano T, Kume H, Takayama K, Murata T, Yamada Y, Obinata D, Inoue S, Homma Y
Organizer
29th Annual Congress of the European Association of Urology
Place of Presentation
Stockholm, Sweden
Year and Date
2014-04-11 – 2014-04-15
Related Report
-
[Presentation] Polyamide targeting transcription of long chain acyl-CoA synthetase 3: A novel therapeutic approach for prostate cancer.2014
Author(s)
Obinata D, Takayama K, Fujiwara K, Fukuda N, Urano T, Ito A, Ashikari D, Murata T, Fujimura T, Ikeda K, Horie-Inoue K, Inoue S, Takahashi S
Organizer
29th Annual Congress of the European Association of Urology
Place of Presentation
Stockholm, Sweden
Year and Date
2014-04-11 – 2014-04-15
Related Report
-
-
-
-
-
-
-
-
-
-
-